Daphne Rivero-Gallegos

Tofacitinib reduces KL-6 levels in patients with rheumatoid arthritis-associated interstitial lung disease. Results of a phase II investigator-initiated study

Jorge Rojas‐Serrano, Espiridión Ramos-Martı́nez, Mayra Mejía, María Fernanda Castillo-López et autres

mx (code pays fourni par la source)

Anti-synthetase Syndrome–Associated Interstitial Lung Disease: Clinical Features and Outcomes Compared with Other ILDs

Sangmee Bae, F. Bozán, Daphne Rivero-Gallegos, Giovanni Zanframundo et autres

it, jp, au, de, us, es, ca, se, kr, gb (code pays fourni par la source)

The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project

Giovanni Zanframundo, Eduardo Dourado, Iazsmin Bauer Ventura, Sara Faghihi‐Kashani et autres

it, pt, us, jp, gb, mx, cl, de, au, es, ca, se, nz, ar, il, tr, fr (code pays fourni par la source)

The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis

Anuradha Bishnoi, Iris Yan Ki Tang, Akira Yoshida, Faye Pais et autres

Idiopathic inflammatory myopathies (IIM), or myositis, are a heterogeneous group of systemic autoimmune disorders that are associated with significant morbidity and mortality. Conducting high-quality clinical trials in IIM is challenging due to the rare and variable presentations of disease. To address this …

in, hk, jp, us, mx, pt, it, cl, gb, ca, Maroc, il, au, tw, cz (code pays fourni par la source)

MUC5B rs35705950 Promoter Variant Is Associated with Usual Interstitial Pneumonia in Patients with Antisynthetase Syndrome

Daphne Rivero-Gallegos, Mayra Mejía, Karol J. Nava-Quiroz, Espiridión Ramos-Martı́nez et autres

Background: The presence of the rs35705950 variant in the MUC5B gene promoter is a critical genetic risk factor in idiopathic pulmonary fibrosis (IPF). It has been associated with usual interstitial pneumonia (UIP) in several interstitial lung diseases (ILDs). In antisynthetase syndrome (ASSD), …

mx (code pays fourni par la source)

Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study

Daphne Rivero-Gallegos, Mayra Mejía, Héctor Isaac Rocha-­González, Juan Carlos Huerta‐Cruz et autres

mx (code pays fourni par la source)

The treatment of interstitial lung disease (ILD) in the context of autoimmune diseases: Rheumatoid arthritis and idiopathic inflammatory myositis

Mayra Mejía, Daphne Rivero-Gallegos, Jorge Rojas‐Serrano

mx (code pays fourni par la source)

The treatment of interstitial lung disease (ILD) in the context of autoimmune diseases: Rheumatoid arthritis and idiopathic inflammatory myositis

Mayra Mejía, Daphne Rivero-Gallegos, Jorge Rojas‐Serrano

mx (code pays fourni par la source)